Search

Author/Creator De Jonge, M.

1. 303 A phase I study of the HDM2 antagonist SAR405838 combined with the MEK inhibitor pimasertib in patients with advanced solid tumors. (September 2015)

Authors:
De Weger, V.; Varga, A.; De Jonge, M.; Langenberg, M.; Mergui-Roelvink, M.; Massard, C.; Van der Vlist, A.; Devriese, L.; Goodstal, S.; Zheng, W.; Tuffal, G.; Semiond, D.; Macé, S.; Watters, J.; Demers, B.; Schellens, J.; Deutsch, E.
Journal:
European journal of cancer
Issue:
Volume 51:(2015)Supplement 3
Page Start:
S55
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Relationships between lines of evidence of pollution in estuarine areas: Linking contaminant levels with biomarker responses in mussels and with structure of macroinvertebrate benthic communities. (October 2016)

Authors:
De los Ríos, A.; Echavarri-Erasun, B.; Lacorte, S.; Sánchez-Ávila, J.; De Jonge, M.; Blust, R.; Orbea, A.; Juanes, J.A.; Cajaraville, M.P.
Journal:
Marine environmental research
Issue:
Volume 121(2016)
Page Start:
49
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗